Initial expression profiling of glioblastoma (GBM) revealed ATF5 expression was inversely correlated with overall patient survival, indicating the importance of ATF5 expression to patient outcomes in the clinic [34, 52]. The gene discussed is ATF5; the disease is glioblastoma.